ATE321867T1 - Zusammensetzungen und methoden zur verwendung von dna polymerasen - Google Patents

Zusammensetzungen und methoden zur verwendung von dna polymerasen

Info

Publication number
ATE321867T1
ATE321867T1 AT00973960T AT00973960T ATE321867T1 AT E321867 T1 ATE321867 T1 AT E321867T1 AT 00973960 T AT00973960 T AT 00973960T AT 00973960 T AT00973960 T AT 00973960T AT E321867 T1 ATE321867 T1 AT E321867T1
Authority
AT
Austria
Prior art keywords
compositions
methods
polymerase
dna polymerases
mutant
Prior art date
Application number
AT00973960T
Other languages
English (en)
Inventor
Joseph A Sorge
Holly H Hogrefe
Connie J Hansen
Original Assignee
Stratagene California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Stratagene California filed Critical Stratagene California
Application granted granted Critical
Publication of ATE321867T1 publication Critical patent/ATE321867T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C12N9/1252—DNA-directed DNA polymerase (2.7.7.7), i.e. DNA replicase
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y10/00—Nanotechnology for information processing, storage or transmission, e.g. quantum computing or single electron logic

Landscapes

  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nanotechnology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medical Informatics (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Mathematical Physics (AREA)
  • Theoretical Computer Science (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
AT00973960T 1999-10-29 2000-10-27 Zusammensetzungen und methoden zur verwendung von dna polymerasen ATE321867T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US16260099P 1999-10-29 1999-10-29

Publications (1)

Publication Number Publication Date
ATE321867T1 true ATE321867T1 (de) 2006-04-15

Family

ID=22586340

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00973960T ATE321867T1 (de) 1999-10-29 2000-10-27 Zusammensetzungen und methoden zur verwendung von dna polymerasen

Country Status (7)

Country Link
US (2) US6946273B1 (de)
EP (1) EP1226255B1 (de)
JP (1) JP4949585B2 (de)
AT (1) ATE321867T1 (de)
AU (1) AU1239901A (de)
DE (1) DE60027040T2 (de)
WO (1) WO2001032887A1 (de)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040009486A1 (en) * 1999-10-29 2004-01-15 Sorge Joseph A. Compositions and methods utilizing DNA polymerases
US20050123940A1 (en) * 1999-10-29 2005-06-09 Stratagene California Compositions and methods for synthesizing cDNA
US8268605B2 (en) 1999-10-29 2012-09-18 Agilent Technologies, Inc. Compositions and methods utilizing DNA polymerases
US20030228616A1 (en) * 1999-10-29 2003-12-11 Stratagene DNA polymerase mutants with reverse transcriptase activity
US20030180741A1 (en) 2001-12-21 2003-09-25 Holly Hogrefe High fidelity DNA polymerase compositions and uses therefor
US6803201B2 (en) 2002-01-24 2004-10-12 Stratagene Compositions and methods for polynucleotide sequence determination
US8283148B2 (en) 2002-10-25 2012-10-09 Agilent Technologies, Inc. DNA polymerase compositions for quantitative PCR and methods thereof
AU2003301590A1 (en) * 2002-10-25 2004-05-13 Stratagene California Dna polymerases with reduced base analog detection activity
US7960157B2 (en) * 2002-12-20 2011-06-14 Agilent Technologies, Inc. DNA polymerase blends and uses thereof
EP1616033B1 (de) 2003-03-25 2010-03-03 Stratagene California Dna-polymerasefusionen und deren verwendungen
GB0321306D0 (en) 2003-09-11 2003-10-15 Solexa Ltd Modified polymerases for improved incorporation of nucleotide analogues
GB0324456D0 (en) * 2003-10-20 2003-11-19 Isis Innovation Parallel DNA sequencing methods
US20100216153A1 (en) 2004-02-27 2010-08-26 Helicos Biosciences Corporation Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities
EP2292767B1 (de) 2004-06-04 2013-11-20 Takara Bio, Inc. Polypeptide mit DNA-Polymeraseaktivität
WO2006120433A1 (en) 2005-05-10 2006-11-16 Solexa Limited Improved polymerases
KR100757280B1 (ko) 2005-11-01 2007-09-11 한국해양연구원 고호열성 신균주 ｋｃｔｃ 10859ｂｐ 및 이로부터 생산되는고호열성 아밀라아제
EP1914303A1 (de) * 2006-10-09 2008-04-23 Qiagen GmbH Thermus eggertssonii DNA Polymerasen
KR100777230B1 (ko) * 2006-11-30 2007-11-28 한국해양연구원 써모코커스 유래 돌연변이 ｄｎａ 중합효소들 및 그의유전자들
JP5386367B2 (ja) 2006-12-29 2014-01-15 アジレント・テクノロジーズ・インク 分断ポリメラーゼを使用する組成物および方法
US20090137405A1 (en) * 2007-11-16 2009-05-28 Christopher Bowman Detection of nucleic acid biomarkers using polymerization-based amplification
US7682809B2 (en) 2008-01-11 2010-03-23 Agilent Technologies, Inc. Direct ATP release sequencing
US10227641B2 (en) 2008-04-30 2019-03-12 Integrated Dna Technologies, Inc. RNase H-based assays utilizing modified RNA monomers
DK2279263T3 (da) 2008-04-30 2013-11-11 Integrated Dna Tech Inc Rnase-h-baserede assays med anvendelse af modificerede rna-monomerer
ES2571446T3 (es) 2008-11-03 2016-05-25 Kapa Biosystems Inc ADN polimerasas quiméricas
WO2010068680A1 (en) 2008-12-10 2010-06-17 Mount Sinai School Of Medicine Of New York University Thelper cell type 17 lineage-specific adjuvants, compositions and methods
US8802375B2 (en) 2009-09-14 2014-08-12 Icahn School Of Medicine At Mount Sinai Methods for characterizing antibody binding affinity and epitope diversity in food allergy
US8715987B2 (en) 2011-05-02 2014-05-06 New England Biolabs, Inc. Solubilized phospholipids for stabilizing nucleic acid polymerases
US8921044B2 (en) 2011-05-11 2014-12-30 New England Biolabs, Inc. DNA polymerase variants with reduced exonuclease activity and uses thereof
US8921043B2 (en) 2011-05-11 2014-12-30 New England Biolabs, Inc. DNA polymerase variants with reduced exonuclease activity and uses thereof
US20140235474A1 (en) 2011-06-24 2014-08-21 Sequenom, Inc. Methods and processes for non invasive assessment of a genetic variation
WO2013052907A2 (en) 2011-10-06 2013-04-11 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US10196681B2 (en) 2011-10-06 2019-02-05 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9367663B2 (en) 2011-10-06 2016-06-14 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9984198B2 (en) 2011-10-06 2018-05-29 Sequenom, Inc. Reducing sequence read count error in assessment of complex genetic variations
US10424394B2 (en) 2011-10-06 2019-09-24 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
ES2929923T3 (es) 2012-01-20 2022-12-02 Sequenom Inc Procesos de diagnóstico que condicionan las condiciones experimentales
US10504613B2 (en) 2012-12-20 2019-12-10 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US9920361B2 (en) 2012-05-21 2018-03-20 Sequenom, Inc. Methods and compositions for analyzing nucleic acid
EP2861757B1 (de) 2012-06-14 2019-11-06 Life Technologies Corporation Neuartige zusammensetzungen, verfahren und kits für polymerasekettenreaktionen (pcr)
US10497461B2 (en) 2012-06-22 2019-12-03 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
JP6478446B2 (ja) 2012-09-28 2019-03-06 東洋紡株式会社 改変された耐熱性ｄｎａポリメラーゼ
US10482994B2 (en) 2012-10-04 2019-11-19 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
US20130309666A1 (en) 2013-01-25 2013-11-21 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
HUE061261T2 (hu) 2013-04-03 2023-05-28 Sequenom Inc Eljárások és folyamatok genetikai variánsok nem invazív értékelésére
WO2014190286A2 (en) 2013-05-24 2014-11-27 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
LT3011051T (lt) 2013-06-21 2019-05-10 Sequenom, Inc. Genetinių variacijų neinvazinis vertinimo būdas
RS59991B1 (sr) 2013-08-08 2020-04-30 Scripps Research Inst Metoda enzimskog in vitro obeležavanja specifičnog za položaj nukleinskih kiselina uvođenjem neprirodnih nukleotida
KR102514024B1 (ko) 2013-10-04 2023-03-23 시쿼넘, 인코포레이티드 유전적 변이의 비침습 평가를 위한 방법 및 프로세스
WO2015054080A1 (en) 2013-10-07 2015-04-16 Sequenom, Inc. Methods and processes for non-invasive assessment of chromosome alterations
EP3068876B1 (de) 2013-11-14 2019-05-08 Integrated DNA Technologies Inc. Dna-polymerase-mutanten mit verbesserter schablonenunterscheidungswirkung
ES2891738T3 (es) 2014-04-09 2022-01-31 Scripps Research Inst Incorporación de nucleósidos trifosfato no naturales o modificados a células a través de transportadores de ácido nucleico trifosfato
WO2016019042A1 (en) 2014-07-30 2016-02-04 Sequenom, Inc. Methods and processes for non-invasive assessment of genetic variations
CN114517189A (zh) 2014-11-14 2022-05-20 亿明达股份有限公司 聚合酶
EP3347461A1 (de) * 2015-09-09 2018-07-18 Qiagen GmbH Polymeraseenzym
WO2017106767A1 (en) 2015-12-18 2017-06-22 The Scripps Research Institute Production of unnatural nucleotides using a crispr/cas9 system
EP3402880B1 (de) 2016-01-15 2024-01-03 Thermo Fisher Scientific Baltics UAB Thermophile dna-polymerase-mutanten
ES2882646T3 (es) 2016-02-29 2021-12-02 Genia Tech Inc Polimerasas carentes de actividad exonucleasa
US20190176153A1 (en) 2016-05-18 2019-06-13 Roche Sequencing Solutions, Inc. Quantitative real time pcr amplification using an electrowetting-based device
US11098360B2 (en) 2016-06-01 2021-08-24 Roche Sequencing Solutions, Inc. Immuno-PETE
US20190218257A1 (en) 2016-06-24 2019-07-18 The Scripps Research Institute Novel nucleoside triphosphate transporter and uses thereof
US10907204B2 (en) 2016-07-12 2021-02-02 Roche Sequencing Solutions, Inc. Primer extension target enrichment
US11200963B2 (en) 2016-07-27 2021-12-14 Sequenom, Inc. Genetic copy number alteration classifications
CA3207879A1 (en) 2017-01-24 2018-08-02 Sequenom, Inc. Methods and processes for assessment of genetic variations
EP3580351A1 (de) * 2017-02-13 2019-12-18 Qiagen Sciences, LLC Polymeraseenzym aus 9°n
WO2018162538A1 (en) 2017-03-08 2018-09-13 F. Hoffmann-La Roche Ag Primer extension target enrichment and improvements thereto including simultaneous enrichment of dna and rna
WO2018191857A1 (zh) * 2017-04-18 2018-10-25 深圳华大智造科技有限公司 Phi29 DNA聚合酶及其编码基因与应用
US11618891B2 (en) 2017-06-26 2023-04-04 Thermo Fisher Scientific Baltics Uab Thermophilic DNA polymerase mutants
AU2018300069A1 (en) 2017-07-11 2020-02-27 Synthorx, Inc. Incorporation of unnatural nucleotides and methods thereof
MX2020001336A (es) 2017-08-03 2020-08-20 Synthorx Inc Conjugados de citoquina para el tratamiento de enfermedades autoinmunes.
JP2022503427A (ja) 2018-10-31 2022-01-12 イラミーナ インコーポレーテッド ポリメラーゼ、組成物、および使用方法
KR20210098844A (ko) 2018-12-05 2021-08-11 일루미나, 인코포레이티드 중합효소, 조성물, 및 사용 방법
MA54952A (fr) 2019-02-06 2022-05-11 Synthorx Inc Conjugués d'il-2 et méthodes d'utilisation de ceux-ci
US11879145B2 (en) 2019-06-14 2024-01-23 The Scripps Research Institute Reagents and methods for replication, transcription, and translation in semi-synthetic organisms
CN114269917A (zh) 2019-08-19 2022-04-01 豪夫迈·罗氏有限公司 用于测序的dna和rna的单管制备
WO2021053008A1 (en) 2019-09-20 2021-03-25 F. Hoffmann-La Roche Ag Immune repertoire profiling by primer extension target enrichment
US20210139867A1 (en) * 2019-11-08 2021-05-13 Omniome, Inc. Engineered polymerases for improved sequencing by binding
US11591629B2 (en) * 2019-12-23 2023-02-28 Cheng-Yao Chen Method and kit for template-independent nucleic acid synthesis
EP4179113A1 (de) 2020-07-08 2023-05-17 F. Hoffmann-La Roche AG Gezielte abreicherung von nichtzielbibliotheksmolekülen unter verwendung von giftprimern während der zielerfassung von sequenzierungsbibliotheken der nächsten generation
US20220177950A1 (en) 2020-12-03 2022-06-09 Roche Sequencing Solutions, Inc. Whole transcriptome analysis in single cells
CA3206360A1 (en) 2020-12-24 2022-06-30 Integrated Dna Technologies, Inc. Rnase h2 mutants that reduce primer dimers and off-target amplification in rhpcr-based amplicon sequencing with high-fidelity dna polymerases
CN112779238B (zh) * 2020-12-28 2024-01-30 广州达安基因股份有限公司 用于丙肝病毒检测的dna聚合酶混合物
US20240117340A1 (en) 2021-02-18 2024-04-11 Roche Sequencing Solutions, Inc. Structure to prevent threading of nucleic acid templates through a nanopore during sequencing
EP4308723A1 (de) 2021-03-15 2024-01-24 F. Hoffmann-La Roche AG Gezielte sequenzierung der nächsten generation über verankerte primerextension
WO2022197589A1 (en) 2021-03-15 2022-09-22 President And Fellows Of Harvard College Methods for in situ sequencing
WO2022207682A1 (en) 2021-04-01 2022-10-06 F. Hoffmann-La Roche Ag Immune cell counting of sars-cov-2 patients based on immune repertoire sequencing
CN114015672B (zh) * 2021-12-06 2022-05-31 江南大学 一种Pfu DNA聚合酶
WO2024003332A1 (en) 2022-06-30 2024-01-04 F. Hoffmann-La Roche Ag Controlling for tagmentation sequencing library insert size using archaeal histone-like proteins

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5674679A (en) 1991-09-27 1997-10-07 Amersham Life Science, Inc. DNA cycle sequencing
US5547859A (en) * 1993-08-02 1996-08-20 Goodman; Myron F. Chain-terminating nucleotides for DNA sequencing methods
EP0655506B1 (de) * 1994-10-17 1996-09-18 President And Fellows Of Harvard College DNS Polymerase mit veränderter Nukleotid-Bindungstelle
US5614365A (en) * 1994-10-17 1997-03-25 President & Fellow Of Harvard College DNA polymerase having modified nucleotide binding site for DNA sequencing
CA2222744C (en) * 1995-05-31 2008-03-25 Amersham Life Science, Inc. Thermostable dna polymerases
AU2804597A (en) 1996-04-15 1997-11-07 University Of Alberta Synthesis of fluorophore-labeled dna
US5882904A (en) 1997-08-04 1999-03-16 Amersham Pharmacia Biotech Inc. Thermococcus barossii DNA polymerase mutants

Also Published As

Publication number Publication date
DE60027040D1 (de) 2006-05-18
WO2001032887A1 (en) 2001-05-10
US6946273B1 (en) 2005-09-20
JP2004500052A (ja) 2004-01-08
EP1226255B1 (de) 2006-03-29
US20050158730A1 (en) 2005-07-21
EP1226255A1 (de) 2002-07-31
AU1239901A (en) 2001-05-14
JP4949585B2 (ja) 2012-06-13
DE60027040T2 (de) 2006-11-23

Similar Documents

Publication Publication Date Title
ATE321867T1 (de) Zusammensetzungen und methoden zur verwendung von dna polymerasen
WO2003054139A3 (en) Compositions and methods utilizing dna polymerases
ATE302279T1 (de) Kälteempfindliche dna-polymerasemutanten
BG100188A (en) Dna sequence enzymes
DE69534855D1 (de) Enzymaktive dna moleküle
WO2001061015A3 (de) Thermostable chimeric nucleic acid polymerases and uses thereof
ATE181106T1 (de) Mutationen in der 5'-3'-exonukleaseaktivität thermostabiler dna-polymerasen
WO2001051006A3 (en) Cardiac-cell specific enhancer elements and uses thereof
DE60131903D1 (de) Direkte multiplex charakterisierung von genomischer dna
WO1995014782A3 (en) A modified thermo resistant dna polymerase
DE69531660D1 (de) Klonierte dna polymerasen aus thermotoga neapolitana und resultierende mutanten
MXPA02012256A (es) Proteinas v de morbillivirus modificados.
WO2002086088A3 (en) Polymerases with charge-switch activity and methods of generating such polymerases
ES2162132T3 (es) Polimerasa de adn termoestable procedente de thermoanaerobacter thermohydrosulfuricus y enzimas mutantes, de actividad exonucleasa suprimida asi obtenidos.
ATE325877T1 (de) Mutierte chimäre dns-polymerasen
ATE557083T1 (de) Thermostabiler oder thermoactiver dna-polymerase mit abgeschwächter 3'-5' exonukleaseaktivität
DE69133629D1 (de) nssystem zur Bestimmung von genetischen Krankheiten
WO2004022770A3 (en) Compositions and methods for synthesizing nucleic acids
WO2021173711A3 (en) Engineered pyrococcus enzymes and uses thereof
ATE277171T1 (de) Ikk-alpha proteine, nukleinsäuren und verfahren
WO2002020735A3 (en) Enzymes having high temperature polymerase activity and methods of use thereof
EP0810288A3 (de) Neue DNA-Polymerase mit 3'-5' Proofreading Exonuklease Atkivität zur Korrekturlesung
AU1070002A (en) Materials and methods relating to nucleic acid amplification and profiling
ATE371022T1 (de) Fy7 polymerase
ATE534731T1 (de) Zusammensetzungen und verfahren zur zufallsmutagenese von nukleinsäuren

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties